206 related articles for article (PubMed ID: 19713997)
1. An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth.
Liu T; Chopra AK
Cancer Gene Ther; 2010 Feb; 17(2):97-108. PubMed ID: 19713997
[TBL] [Abstract][Full Text] [Related]
2. Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines.
Liu T; König R; Sha J; Agar SL; Tseng CT; Klimpel GR; Chopra AK
Microb Pathog; 2008 Mar; 44(3):224-37. PubMed ID: 17997275
[TBL] [Abstract][Full Text] [Related]
3. Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection.
Fadl AA; Sha J; Klimpel GR; Olano JP; Niesel DW; Chopra AK
Infect Immun; 2005 Feb; 73(2):1081-96. PubMed ID: 15664952
[TBL] [Abstract][Full Text] [Related]
4. Protective Immunity Elicited by Oral Immunization of Mice with
Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of Salmonella enterica Serovar Typhimurium by altering biological functions of murein lipoprotein and lipopolysaccharide.
Fadl AA; Sha J; Klimpel GR; Olano JP; Galindo CL; Chopra AK
Infect Immun; 2005 Dec; 73(12):8433-6. PubMed ID: 16299345
[TBL] [Abstract][Full Text] [Related]
6. Global gene expression of a murein (Braun) lipoprotein mutant of Salmonella enterica serovar Typhimurium by microarray analysis.
Fadl AA; Galindo CL; Sha J; Klimpel GR; Popov VL; Chopra AK
Gene; 2006 Jun; 374():121-7. PubMed ID: 16574345
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant.
Kong Q; Six DA; Liu Q; Gu L; Roland KL; Raetz CR; Curtiss R
Infect Immun; 2011 Dec; 79(12):5027-38. PubMed ID: 21930761
[TBL] [Abstract][Full Text] [Related]
8. The two murein lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism.
Sha J; Fadl AA; Klimpel GR; Niesel DW; Popov VL; Chopra AK
Infect Immun; 2004 Jul; 72(7):3987-4003. PubMed ID: 15213144
[TBL] [Abstract][Full Text] [Related]
9. Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant.
Lee SR; Kim SH; Jeong KJ; Kim KS; Kim YH; Kim SJ; Kim E; Kim JW; Chang KT
J Microbiol Biotechnol; 2009 Oct; 19(10):1271-9. PubMed ID: 19884791
[TBL] [Abstract][Full Text] [Related]
10. Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes.
Matsui H; Fukiya S; Kodama-Akaboshi C; Eguchi M; Yamamoto T
J Med Microbiol; 2015 Mar; 64(Pt 3):295-302. PubMed ID: 25589672
[TBL] [Abstract][Full Text] [Related]
11. Salmonella enterica serovar Typhimurium ΔmsbB triggers exacerbated inflammation in Nod2 deficient mice.
Claes AK; Steck N; Schultz D; Zähringer U; Lipinski S; Rosenstiel P; Geddes K; Philpott DJ; Heine H; Grassl GA
PLoS One; 2014; 9(11):e113645. PubMed ID: 25423082
[TBL] [Abstract][Full Text] [Related]
12. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
[TBL] [Abstract][Full Text] [Related]
14. msbB deletion confers acute sensitivity to CO2 in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwf.
Karsten V; Murray SR; Pike J; Troy K; Ittensohn M; Kondradzhyan M; Low KB; Bermudes D
BMC Microbiol; 2009 Aug; 9():170. PubMed ID: 19689794
[TBL] [Abstract][Full Text] [Related]
15. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
[TBL] [Abstract][Full Text] [Related]
16. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
Łaniewski P; Baek CH; Roland KL; Curtiss R
mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
[No Abstract] [Full Text] [Related]
18. Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccines.
Sydenham M; Douce G; Bowe F; Ahmed S; Chatfield S; Dougan G
Infect Immun; 2000 Mar; 68(3):1109-15. PubMed ID: 10678914
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers.
Angelakopoulos H; Hohmann EL
Infect Immun; 2000 Apr; 68(4):2135-41. PubMed ID: 10722611
[TBL] [Abstract][Full Text] [Related]
20. Salmonella enterica serovar typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261.
Peters SE; Paterson GK; Bandularatne ES; Northen HC; Pleasance S; Willers C; Wang J; Foote AK; Constantino-Casas F; Scase TJ; Blacklaws BA; Bryant CE; Mastroeni P; Charles IG; Maskell DJ
Infect Immun; 2010 Jan; 78(1):326-36. PubMed ID: 19884329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
